Meridian Bioscience | VIVO - Assets

Meridian Bioscience reported $463.1M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Accelerate Diagnostics AXDX:US USD 75.85M 17.12M
Atrion ATRI:US USD 264.71M 10.6M
Becton, Dickinson and BDX:US USD 53.13B 195M
Bio Rad Laboratories BIO:US USD 13.5B 1.44B
Cerus CERS:US USD 218.09M 2.69M
Myriad Genetics MYGN:US USD 1.2B 13.3M
Neogen NEOG:US USD 4.56B 3.59B
Orasure Technologies OSUR:US USD 444.71M 12.5M
Quidel QDEL:US USD 8.86B 200.3M
Rockwell Medical RMTI:US USD 54.19M 4.93M
Sientra SIEN:US USD 165.93M 9.25M
Staar Surgical STAA:US USD 414.9M 20.22M
Thermo Fisher Scientific TMO:US USD 97.29B 6.75B
Utah Medical Products UTMD:US USD 118.41M 2.26M